TY - JOUR
T1 - Exercise-induced fatigue in severe hypoxia following an intermittent hypoxic protocol
AU - Twomey, Rosemary
AU - Wrightson, James
AU - Fletcher, Hannah
AU - Avraam, Stephanie
AU - Ross, Emma
AU - Dekerle, Jeanne
N1 - This is not the final published version. The final published version can be found at http://journals.lww.com/acsm-msse/fulltext/9000/00000/Exercise_Induced_Fatigue_in_Severe_Hypoxia.97160.aspx
PY - 2017/6/30
Y1 - 2017/6/30
N2 - PURPOSE: Exercise-induced central fatigue is alleviated following acclimatisation to high altitude. The adaptations underpinning this effect may also be induced with brief, repeated exposures to severe hypoxia. The purpose of this study was to determine whether (i) exercise tolerance in severe hypoxia would be improved following an intermittent hypoxic (IH) protocol and (ii) exercise-induced central fatigue would be alleviated following an IH protocol.METHODS: Nineteen recreationally-active males were randomised into two groups who completed ten 2-h exposures in severe hypoxia (IH: PIO2 82 mmHg; n=11) or normoxia (control; n=8). Seven sessions involved cycling for 30 min at 25% peak power (W˙peak) in IH, and at a matched heart rate in normoxia. Participants performed baseline constant-power cycling to task failure in severe hypoxia (TTF-Pre). After the intervention, the cycling trial was repeated (TTF-Post). Pre- and post-exercise, responses to transcranial magnetic stimulation and supramaximal femoral nerve stimulation were obtained to assess central and peripheral contributions to neuromuscular fatigue.RESULTS: From pre- to post-exercise in TTF-Pre, maximal voluntary force (MVC), cortical voluntary activation (VATMS) and potentiated twitch force (Qtw,pot) decreased in both groups (all p < 0.05). Following IH, TTF-Post was improved (535 ± 213 s vs. 713 ± 271 s, p < 0.05) and an additional isotime trial was performed. After the IH intervention only, the reduction in MVC and VATMS was attenuated at isotime (p < 0.05). No differences were observed in the control group.CONCLUSION: Whole-body exercise tolerance in severe hypoxia was prolonged following a protocol of IH. This may be related to an alleviation of the central contribution to neuromuscular fatigue.
AB - PURPOSE: Exercise-induced central fatigue is alleviated following acclimatisation to high altitude. The adaptations underpinning this effect may also be induced with brief, repeated exposures to severe hypoxia. The purpose of this study was to determine whether (i) exercise tolerance in severe hypoxia would be improved following an intermittent hypoxic (IH) protocol and (ii) exercise-induced central fatigue would be alleviated following an IH protocol.METHODS: Nineteen recreationally-active males were randomised into two groups who completed ten 2-h exposures in severe hypoxia (IH: PIO2 82 mmHg; n=11) or normoxia (control; n=8). Seven sessions involved cycling for 30 min at 25% peak power (W˙peak) in IH, and at a matched heart rate in normoxia. Participants performed baseline constant-power cycling to task failure in severe hypoxia (TTF-Pre). After the intervention, the cycling trial was repeated (TTF-Post). Pre- and post-exercise, responses to transcranial magnetic stimulation and supramaximal femoral nerve stimulation were obtained to assess central and peripheral contributions to neuromuscular fatigue.RESULTS: From pre- to post-exercise in TTF-Pre, maximal voluntary force (MVC), cortical voluntary activation (VATMS) and potentiated twitch force (Qtw,pot) decreased in both groups (all p < 0.05). Following IH, TTF-Post was improved (535 ± 213 s vs. 713 ± 271 s, p < 0.05) and an additional isotime trial was performed. After the IH intervention only, the reduction in MVC and VATMS was attenuated at isotime (p < 0.05). No differences were observed in the control group.CONCLUSION: Whole-body exercise tolerance in severe hypoxia was prolonged following a protocol of IH. This may be related to an alleviation of the central contribution to neuromuscular fatigue.
U2 - 10.1249/MSS.0000000000001371
DO - 10.1249/MSS.0000000000001371
M3 - Article
SN - 0195-9131
VL - 49
SP - 2422
EP - 2432
JO - Medicine and science in sports and exercise
JF - Medicine and science in sports and exercise
IS - 12
ER -